Legal Representation
Attorney
Anne Fleeson
USPTO Deadlines
Next Deadline
61 days remaining
Non-Final Action Mailed
Due Date
September 30, 2025
Extension Available
Until December 30, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 2, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 2, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 2, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 2, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 2, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 17, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 17, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 7, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 7, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)
Class 044
Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer; providing medical information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)
Additional Information
Design Mark
The mark consists of Two ovals intersecting with a “Q” in the middle along with the words QuantumAI.
Pseudo Mark
QUANTUM QUANTUM AI
Pseudo Mark
QUANTUM QUANTUM ARTIFICIAL INTELLIGENCE
Classification
International Classes
042
044